Status:
COMPLETED
Thrombolysis in Myocardial Infarction (TIMI)
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Coronary Disease
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
In TIMI I, to assess the relative thrombolytic activity and side effects of intravenous recombinant tissue-type plasminogen activator (rt-PA) versus intravenous streptokinase in patients with acute my...
Detailed Description
BACKGROUND: Coronary artery disease is the leading cause of death in the United States, accounting for almost 500,000 deaths each year. Studies have confirmed that myocardial infarction is related to...
Eligibility Criteria
Men and women under age 76. Patients had acute myocardial infarction.
Key Trial Info
Start Date :
April 1 1983
Trial Type :
INTERVENTIONAL
End Date :
December 1 1990
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000505
Start Date
April 1 1983
End Date
December 1 1990
Last Update
March 16 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.